Clinical Trials Browser

Unknown × Observational × Drug Therapy × Clear all

NCT03253107 2023-10-04

Predicting Biomarker of Gastric Cancer Chemotherapy Response

Gastrointestinal

Stomach Neoplasms

NCT05873790 2023-05-24

Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04359199 2023-02-10

QUASAR

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT02428049 2023-01-20

Radiation Pneumonitis After SBRT for NSCLC

Lung Neoplasms

NCT05680194 2023-01-11

EEBC

Breast Neoplasms

NCT05609162 2022-12-15

TBMPPF

Brain Neoplasms

NCT04574245 2022-10-05

RECORD

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

NCT03794193 2022-05-04

The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer

Gastrointestinal

Colonic Neoplasms

NCT02067052 2022-04-15

New Strategy for the Treatment of Vulvar Cancer

Vulvar Neoplasms

NCT05322486 2022-04-11

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases

Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms, Neoplasms, Second Primary

NCT02254941 2022-03-16

Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

Gastrointestinal

Colonic Neoplasms

NCT05188495 2022-01-12

HELP

HER2-positive Metastatic Breast Cancer

NCT04341480 2021-10-07

The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19

COVID-19

NCT03521245 2021-09-14

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Breast Neoplasms

NCT05028231 2021-08-31

NICCE

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02753036 2021-08-19

CICARO

Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Neoplasms, Polyneuropathies

NCT04495387 2021-04-27

Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT04672759 2020-12-17

A Real-world Study of Durvalumab for Lung Cancer in China

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT02251353 2020-02-21

IMET

Breast Neoplasms, Neoplasm Metastasis

NCT03771625 2019-07-29

Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors

Intracranial Germ Cell Tumor

NCT03966456 2019-05-29

Real World Study of Four PD-1 Agents in China

Abdominal Neoplasms, Melanoma

NCT03932058 2019-05-02

PROS001

Osteosarcoma

NCT03177902 2017-06-07

Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

Thyroid Diseases

NCT03062072 2017-04-07

ECHO

BreastGastrointestinalLymphoid

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Neoplasms

NCT00173472 2005-11-24

Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer

Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability